Strategies for Removal of Protein-Bound Uremic Toxins in Hemodialysis
Toxins · 22.01.2026 · 18 (1) · 57
DOI: 10.3390/toxins18010057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 22.01.2026. Verfasst von Joost C de Vries und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Uremic Toxins, Renal Dialysis, Uremia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nierstichting, European Commission (KIDNEW, HORIZON-EIC-2022 Pathfinder program), Dutch organization for Scientific Research (NWO-TTW).
Abstract (Originalsprache)
The removal of protein-bound uremic toxins (PBUTs) from the blood of kidney failure patients with conventional dialysis is limited. However, as their harmful effects and association with morbidity and mortality in dialysis patients are increasingly recognized, PBUTs have become important therapeutic targets. In this review, PBUT removal with current state-of-the-art dialysis technologies and future perspectives are discussed. Strategies to enhance PBUT clearance include methods that interfere with PBUT–albumin binding, such as chemical displacers, high ionic strength, pH changes, or electromagnetic fields, thereby increasing the free fraction available for dialysis. While these methods have shown promise in vitro, and some also in vivo, long-term safety data are lacking. PBUT removal can also be increased by adsorption, either directly via hemoperfusion, or indirectly, e.g., via sorbents incorporated in a mixed-matrix membrane or dissolved in the dialysate. In the kidney, PBUTs are secreted in the proximal tubules; hence, a cell-based bioartificial kidney (BAK) that secretes PBUTs is proposed as an add-on to current dialysis. Yet both PBUT adsorption strategies and, in particular, BAKs face considerable challenges in upscaling and mass production at acceptable costs. In conclusion, many novel technologies are under development, all requiring further (pre)clinical testing and upscaling before these strategies can be applied in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Hypertension, University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands.
- BIOS Lab on a Chip Group, Faculty of EEMCS, University of Twente, 7500 AE Enschede, The Netherlands.
- IMEC the Netherlands-Health Research, 5656 AE Eindhoven, The Netherlands.
- European Kidney Health Alliance (EKHA, WG3), 1000 Brussels, Belgium.
- Aachen-Maastricht Institute for Cardiorenal Disease (AMICARE), University Hospital RWTH Aachen, 52074 Aachen, Germany.
- Advanced Organ Bioengineering and Therapeutics, Faculty of Science and Technology, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.
ORCID-Profile: João G Brás, Jeroen C Vollenbroek, Fokko P Wieringa, Marianne C Verhaar, Dimitrios Stamatialis, Rosalinde Masereeuw, Karin G F Gerritsen
Förderung
- Nierstichting
- European Commission (KIDNEW, HORIZON-EIC-2022 Pathfinder program)
- Dutch organization for Scientific Research (NWO-TTW)
- Kidney Innovation Accelerator KidneyX prize
- Dutch national growth fund (NXTGEN HighTech)
- European Renal Association-European Dialysis Transplantation Association (ERA-EDTA)
- Dutch Kidney Foundation
- Strategic alliance of the University of Twente, University of Utrecht, and University Medical Center Utrecht, of the Dutch organization for Scientific Research
Zitieren
APA
de Vries, J. C., Brás, J. G., de Vries, G. M., Vollenbroek, J. C., Wieringa, F. P., Jankowski, J., Verhaar, M. C., Stamatialis, D., Masereeuw, R., & Gerritsen, K. G. F. (2026). Strategies for Removal of Protein-Bound Uremic Toxins in Hemodialysis. Toxins, 18(1), 57. https://doi.org/10.3390/toxins18010057
Vancouver
de Vries JC, Brás JG, de Vries GM, Vollenbroek JC, Wieringa FP, Jankowski J, et al. Strategies for Removal of Protein-Bound Uremic Toxins in Hemodialysis. Toxins. 2026;18(1):57. doi:10.3390/toxins18010057
BibTeX
@article{deVries2026,
author = {de Vries, Joost C and Brás, João G and de Vries, Geert M and Vollenbroek, Jeroen C and Wieringa, Fokko P and Jankowski, Joachim and Verhaar, Marianne C and Stamatialis, Dimitrios and Masereeuw, Rosalinde and Gerritsen, Karin G F},
title = {Strategies for Removal of Protein-Bound Uremic Toxins in Hemodialysis},
journal = {Toxins},
year = {2026},
volume = {18},
number = {1},
pages = {57},
doi = {10.3390/toxins18010057}
}
EUVIMED